ZFP36L2 Is a Potential Prognostic Marker of IL1β<sup>+</sup> Osteosarcoma
<b>Background:</b> Osteosarcoma stands as the predominant bone malignancy afflicting children and young adults. Despite strides in treatment, the enduring reality is that the long-term survival rates for patients grappling with recurrences and metastases linger at a mere 30%. This unders...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/12/12/2861 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|